These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11549403

  • 1. Linked polymorphisms (-333G>T and -286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia.
    Tachikawa H, Harada S, Kawanishi Y, Okubo T, Suzuki T.
    Psychiatry Res; 2001 Sep 20; 103(2-3):147-55. PubMed ID: 11549403
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms of the CCK, CCKAR and CCKBR genes: an association with alcoholism study.
    Okubo T, Harada S.
    J Stud Alcohol; 2001 Jul 20; 62(4):413-21. PubMed ID: 11513220
    [Abstract] [Full Text] [Related]

  • 3. Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia.
    Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H.
    Am J Med Genet; 2000 Apr 03; 96(2):141-5. PubMed ID: 10893485
    [Abstract] [Full Text] [Related]

  • 4. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
    Goldman JG, Goetz CG, Berry-Kravis E, Leurgans S, Zhou L.
    Arch Neurol; 2004 Aug 03; 61(8):1280-4. PubMed ID: 15313848
    [Abstract] [Full Text] [Related]

  • 5. Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism.
    Okubo T, Harada S, Higuchi S, Matsushita S.
    Alcohol Clin Exp Res; 2002 Aug 03; 26(8 Suppl):2S-5S. PubMed ID: 12198366
    [Abstract] [Full Text] [Related]

  • 6. Novel polymorphism in the promoter and coding regions of the human cholecystokinin B receptor gene: an association analysis with schizophrenia.
    Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H.
    Am J Med Genet; 1999 Dec 15; 88(6):700-4. PubMed ID: 10581492
    [Abstract] [Full Text] [Related]

  • 7. A possible association between the CCK-AR gene and persistent auditory hallucinations in schizophrenia.
    Sanjuan J, Toirac I, González JC, Leal C, Moltó MD, Nájera C, De Frutos R.
    Eur Psychiatry; 2004 Sep 15; 19(6):349-53. PubMed ID: 15363473
    [Abstract] [Full Text] [Related]

  • 8. Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNFα) gene polymorphisms with paranoid schizophrenia in a Polish population.
    Paul-Samojedny M, Owczarek A, Kowalczyk M, Suchanek R, Palacz M, Kucia K, Fila-Daniłow A, Borkowska P, Kowalski J.
    J Neuropsychiatry Clin Neurosci; 2013 Sep 15; 25(1):72-82. PubMed ID: 23487197
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
    Ozbey U, Tug E, Namli M.
    World J Biol Psychiatry; 2009 Sep 15; 10(4 Pt 2):461-8. PubMed ID: 19153889
    [Abstract] [Full Text] [Related]

  • 10. The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia.
    Wei J, Hemmings GP.
    Eur Psychiatry; 1999 Apr 15; 14(2):67-70. PubMed ID: 10572328
    [Abstract] [Full Text] [Related]

  • 11. Association between CCK-AR gene and schizophrenia with auditory hallucinations.
    Toirac I, Sanjuán J, Aguilar EJ, González JC, Artigas F, Rivero O, Nájera C, Moltó MD, de Frutos R.
    Psychiatr Genet; 2007 Apr 15; 17(2):47-53. PubMed ID: 17413443
    [Abstract] [Full Text] [Related]

  • 12. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
    Peñas-Lledó EM, Dorado P, Cáceres MC, de la Rubia A, Llerena A.
    Clin Chem Lab Med; 2007 Apr 15; 45(7):835-8. PubMed ID: 17617023
    [Abstract] [Full Text] [Related]

  • 13. Association study between the cholecystokinin A receptor gene and schizophrenia in the Japanese population.
    Minato T, Tochigi M, Kato N, Sasaki T.
    Psychiatr Genet; 2007 Apr 15; 17(2):117-9. PubMed ID: 17413452
    [Abstract] [Full Text] [Related]

  • 14. Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene in schizophrenia.
    Xing QH, Wu SN, Lin ZG, Li HF, Yang JD, Feng GY, Wang MT, Yang WW, He L.
    Schizophr Res; 2003 Dec 01; 65(1):9-14. PubMed ID: 14623368
    [Abstract] [Full Text] [Related]

  • 15. Investigation of allelic heterogeneity of the CCK-A receptor gene in paranoid schizophrenia.
    Zheng C, Fu Q, Shen Y, Xu Q.
    Am J Med Genet B Neuropsychiatr Genet; 2012 Sep 01; 159B(6):741-7. PubMed ID: 22825913
    [Abstract] [Full Text] [Related]

  • 16. Association study of interleukin-4 polymorphisms with paranoid schizophrenia in the Polish population: a critical approach.
    Fila-Danilow A, Kucia K, Kowalczyk M, Owczarek A, Paul-Samojedny M, Borkowska P, Suchanek R, Kowalski J.
    Mol Biol Rep; 2012 Aug 01; 39(8):7941-7. PubMed ID: 22528336
    [Abstract] [Full Text] [Related]

  • 17. Possible association of a cholecystokinin promoter variant to schizophrenia.
    Wang Z, Wassink T, Andreasen NC, Crowe RR.
    Am J Med Genet; 2002 Jul 08; 114(5):479-82. PubMed ID: 12116180
    [Abstract] [Full Text] [Related]

  • 18. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
    Rohrmeier T, Putzhammer A, Sartor H, Knapp M, Albus M, Borrmann-Hassenbach M, Lichtermann D, Wildenauer D, Schwab S, Maier W, Klein HE, Eichhammer P.
    Psychiatr Prax; 2003 May 08; 30 Suppl 2():S212-5. PubMed ID: 14509080
    [Abstract] [Full Text] [Related]

  • 19. Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia.
    Hattori M, Kunugi H, Akahane A, Tanaka H, Ishida S, Hirose T, Morita R, Yamakawa K, Nanko S.
    Am J Med Genet; 2002 Apr 08; 114(3):304-9. PubMed ID: 11920853
    [Abstract] [Full Text] [Related]

  • 20. Supportive evidence for the association between the T102C 5-HTR2A gene polymorphism and schizophrenia: a large-scale case-control and family-based study.
    Golimbet VE, Lavrushina OM, Kaleda VG, Abramova LI, Lezheiko TV.
    Eur Psychiatry; 2007 Apr 08; 22(3):167-70. PubMed ID: 17240119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.